FDA Approves Viread(R) For Chronic Hepatitis B In Adults (Medical News Today)
Gilead Sciences, Inc. (NASDAQ:GILD) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B, a serious liver disease caused by the hepatitis B virus (HBV).

Alcohol Dependence Drug Can Cause Adverse Reactions Warned FDA (Medical News Today)
The US Food and Drug Administration (FDA) issued an alert to healthcare professionals on Tuesday advising them of the risk of adverse injection site reactions in patients given injections of Vivitrol (generic name naltrexone), a drug that is used to treat alcohol dependence. Vivitrol ( naltrexone) is marketed in the US by Cephalon Inc.

Duska Therapeutics Receives Comments From FDA On Phase 3 ATPace(TM) Protocol Synopsis (Medical News Today)
Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) ("Duska") announced that it has received comments from the U.S.